Apex Healthcare Berhad (KLSE:AHEALTH)

Market Cap	1.76B
Revenue (ttm)	952.47M
Net Income (ttm)	72.92M
Shares Out	720.39M
EPS (ttm)	0.10
PE Ratio	23.94
Forward PE	20.22
Dividend	0.09 (3.67%)
Ex-Dividend Date	May 30, 2025

Volume	90,500
Average Volume	126,520
Open	2.440
Previous Close	2.450
Day's Range	2.380 - 2.440
52-Week Range	1.900 - 2.820
Beta	0.31
RSI	62.03
Earnings Date	Aug 20, 2025

About Accolade

Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, anti-diabetic, anti-hypertensive, neuromuscular agent, analgesic, dermatological, and ophthalmological products in the form of tablets, capsules, oral liq...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 976
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: AHEALTH

Financial Performance

In 2024, Apex Healthcare Berhad's revenue was 961.78 million, an increase of 2.74% compared to the previous year's 936.17 million. Earnings were 76.54 million, a decrease of -80.77%.